The decision issued Friday is the first of several lawsuits filed by pharmaceutical companies in opposition to certain provisions of the law, the Inflation Reduction Act (IRA).
Colm Connolly, U.S. District Court's chief judge for Delaware, stated that the harm AstraZeneca claimed is not concrete, emphasizing it as speculative.
[
add
]
[
|
|
...
]